Nate Collins, DVM, PhD, DACVP

SENIOR CONSULTANT, NONCLINICAL TOXICOLOGY
ToxStrategies

I am a clinical pathologist by training with 25 years’ experience in large pharma developing small and large molecules and novel modalities, including cell therapies, or oncology, immunology, CNS, infectious disease, and cardiovascular indications. I have led investigative toxicology, genetic toxicology, immunotoxicology, and biomarker discovery groups. The last 15 years of my career were spent overseeing nonclinical safety strategy for the portfolio of two pharma R&D organizations. I have made substantial contributions to the successful approval of 19 marketed drugs as well as numerous other development candidates, from preclinical through Phase 3 clinical development and post-marketing commitments. I leverage this experience as well as extensive health authority interactions to help clients solve challenging preclinical problems and progress their molecules.